The Sky Shop For Hope
Awareness Towel (Dino Blue Waves)
Awareness Towel (Dino Blue Waves)
Couldn't load pickup availability
Give your bathroom, beach day, or gym bag a meaningful upgrade with this ultra-soft purple pancreatic cancer awareness towel. Featuring a vibrant all-over purple design, this cozy towel supports Sky Foundation’s mission to fund research, raise awareness, and bring hope to those impacted by pancreatic cancer.
Made from a premium cotton-polyester blend, the printed side delivers striking color and style, while the terry cloth back ensures excellent absorbency. It’s more than just a towel—it’s a symbol of strength and solidarity.
💜 A percentage of every purchase supports pancreatic cancer research through Sky Foundation, helping move us closer to a world with earlier detection, better treatments, and brighter futures.
⭐ Features & Benefits
Super-soft 52% cotton / 48% polyester blend (US), 50/50 in EU
Large, versatile size: 30″ × 60″
Plush fabric weight: 10.6–11.8 oz./yd²
One-sided sublimation print with vivid purple design
Terry cloth back for maximum water absorbency
Lightweight yet durable for everyday comfort
Why It Matters:
Every towel you use becomes a small act of impact. Support research. Share hope. Show up for the fight against pancreatic cancer—one meaningful purchase at a time.
Share






Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...